Global Tumor Ablation Market - Industry Outlook Research, Market Forecast & Growth Till 2024
According to Data Bridge Market Research new Market report “Global Tumor Ablation Market, By Type (Tumor Ablation Systems (Radio Frequency Ablation, Microwave Ablation, HIFU, Laser Ablation, Cryoablation), Image Guidance Products, Accessories), By Cancer Type (Liver, Lings, Kidney, Brain, Bone, Pancreas, Breast, Others), By End-User (Hospitals, Oncology Clinics, Others), By Geography (North America, South America, Europe, Asia-Pacific, Rest of the World) – Trends and Forecast to 2022”, has accounted for USD 1.7 billion in 2015, and is expected to reach USD 2.9 billion by 2022, growing at a CAGR 8.2% during the forecast period 2016 to 2022.
Get free sample @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-tumour-ablation-market
The global tumor ablation market is expected to grow, owing to factors such as rising cancer incidence, increased focus on treatment of breast cancer, better reimbursement scenarios, shift towards value based reimbursements and continuous development in ablation technology. The ablation technology has an upper edge on chemotherapy and other oncology therapeutics. However ablation technology can only be used to treat tumours with size less than 3cm, owing to the healthy tissue damage caused by it. With the advent of guidance mechanisms such as ultrasounds and MRI the accuracy of the treatment has increased significantly in the past 5 years.
Segmentation: Tumor Ablation Market Market
• The global tumor ablation market is segmented based on product types, cancer types, end-user and geography.
• The global tumor ablation market is segmented into 3 type’s ablation systems, image guidance products and accessories. The ablation systems dominates the market and is further segmented based on product type into microwave ablation (coretherm thermotherapy devices and prolieve thermotherapy devices), radiofrequency ablation (RFA) ((temperature controlled devices, fluid cooled, catheter manipulation systems), high intensity focused ultrasound (HIFU), laser ablation and cryoablation.
• On the basis of cancer types treated using ablation devices the market is segmented into liver, lings, kidney, brain, bone, pancreas, breast and, other cancer types.
• Based on end-user the global tumor ablation market is segmented into hospitals, oncology clinics and others.
Inquire before buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-tumour-ablation-market
Geographical Segmentation: Tumor Ablation Market
Based on geography the global tumor ablation market is segmented into 5 geographical regions,
• Europe,
• Asia-Pacific,
• North America,
• South America and
• rest of the world.
The geographical regions are further segmented into 24 major countries such as U.S., Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others. In 2016, Europe is expected to dominate the market with 36.7% market share, owing to the large incidence of cancer patients in this region coupled with good reimbursements.
Competitive Landscape: Tumor Ablation Market
The tumor ablation market’s major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. Some examples of recent strategies/developments are: On January, 2016 Medtronic acquired OsteoCool RF Ablation System from Baylis Medical and received its FDA approval, December, 2015 DFINE, Inc. launched Long SpineStar ablation system, January 2015, Medtronic acquired Covidien to strengthen its leadership in medical devices industry among others. The report includes market shares of tumor ablation market for global, Europe, North America, Asia Pacific and Rest of the World.
In 2015, Medtronic has dominated the global tumor ablation market.
Some of the other key players operating in this market are
• Galil Medical, Inc.,
• Perseon Corporation,
• Mermaid Medical A/S,
• SonaCare Medical,
• LLC,
• Koninklijke Philips N.V., INTIO Inc.,
• AngioDynamics, Inc.,
• COMSOL Inc.,
• DFINE, Inc.,
• Misonix, Inc.,
• BVM Medical Limited,
• NeuWave Medical, Inc.,
• Boston Scientific Corporation,
• EDAP TMS S.A. and,
• HealthTronics, Inc. among other companies.
Access Report: https://databridgemarketresearch.com/reports/global-tumour-ablation-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
Get free sample @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-tumour-ablation-market
The global tumor ablation market is expected to grow, owing to factors such as rising cancer incidence, increased focus on treatment of breast cancer, better reimbursement scenarios, shift towards value based reimbursements and continuous development in ablation technology. The ablation technology has an upper edge on chemotherapy and other oncology therapeutics. However ablation technology can only be used to treat tumours with size less than 3cm, owing to the healthy tissue damage caused by it. With the advent of guidance mechanisms such as ultrasounds and MRI the accuracy of the treatment has increased significantly in the past 5 years.
Segmentation: Tumor Ablation Market Market
• The global tumor ablation market is segmented based on product types, cancer types, end-user and geography.
• The global tumor ablation market is segmented into 3 type’s ablation systems, image guidance products and accessories. The ablation systems dominates the market and is further segmented based on product type into microwave ablation (coretherm thermotherapy devices and prolieve thermotherapy devices), radiofrequency ablation (RFA) ((temperature controlled devices, fluid cooled, catheter manipulation systems), high intensity focused ultrasound (HIFU), laser ablation and cryoablation.
• On the basis of cancer types treated using ablation devices the market is segmented into liver, lings, kidney, brain, bone, pancreas, breast and, other cancer types.
• Based on end-user the global tumor ablation market is segmented into hospitals, oncology clinics and others.
Inquire before buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-tumour-ablation-market
Geographical Segmentation: Tumor Ablation Market
Based on geography the global tumor ablation market is segmented into 5 geographical regions,
• Europe,
• Asia-Pacific,
• North America,
• South America and
• rest of the world.
The geographical regions are further segmented into 24 major countries such as U.S., Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others. In 2016, Europe is expected to dominate the market with 36.7% market share, owing to the large incidence of cancer patients in this region coupled with good reimbursements.
Competitive Landscape: Tumor Ablation Market
The tumor ablation market’s major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. Some examples of recent strategies/developments are: On January, 2016 Medtronic acquired OsteoCool RF Ablation System from Baylis Medical and received its FDA approval, December, 2015 DFINE, Inc. launched Long SpineStar ablation system, January 2015, Medtronic acquired Covidien to strengthen its leadership in medical devices industry among others. The report includes market shares of tumor ablation market for global, Europe, North America, Asia Pacific and Rest of the World.
In 2015, Medtronic has dominated the global tumor ablation market.
Some of the other key players operating in this market are
• Galil Medical, Inc.,
• Perseon Corporation,
• Mermaid Medical A/S,
• SonaCare Medical,
• LLC,
• Koninklijke Philips N.V., INTIO Inc.,
• AngioDynamics, Inc.,
• COMSOL Inc.,
• DFINE, Inc.,
• Misonix, Inc.,
• BVM Medical Limited,
• NeuWave Medical, Inc.,
• Boston Scientific Corporation,
• EDAP TMS S.A. and,
• HealthTronics, Inc. among other companies.
Access Report: https://databridgemarketresearch.com/reports/global-tumour-ablation-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com